A systematic review of guidelines for dual antiplatelet therapy in coronary artery bypass graft.
Zheng-Zhi-Peng ZhangShao-Zhao ZhangHui-Min ZhouYong-Qiang FanMeng-Hui LiuXiang-Bin ZhongDa-Ya YangYue GuoXiao-Dong ZhuangXin-Xue LiaoPublished in: European journal of clinical investigation (2020)
Current guidelines on DAPT in CABG are generally satisfying. Suspending P2Y12 inhibitors while aspirin continued before elective CABG is recommended, as well as 12 months of DAPT following CABG. More evidence is needed to guide antiplatelet therapy in urgent CABG and to prove the benefits of resuming previous DAPT.